– Study Met Primary Endpoint; Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in…
Robust decreases in serum IgM at low- and mid-doses suggest best-in-class potential for mavorixafor plus…
Analysis from Phase 2a HOPE-KIDS 1 Study Featured in Oral Presentation Two Real-world Data Studies…
Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0%…
Data from JEWELFISH, the first trial in a diverse population aged 1 to 60 years…
Listing Transition to Proceed as Previously Announced to Maintain Regulatory Compliance as a U.S.-Based, Plant-Touching…
Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting…
BELTSVILLE, Md., June 10, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today that…
Submitted first premarket approval (PMA) application in the Company’s history to FDA for LungFit® PH…
– Webinar on Monday, June 21, 2021 at 11:00 a.m. ET – MONTREAL, June 10,…
VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) — Segra International Corp, a leading cannabis…
SUWON, Republic of Korea, June 10, 2021 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950),…
Astronomy Meets Pathology for Immunotherapy Research The Johns Hopkins AstroPath™ team used Akoya’s Phenoptics technology…
Online Event Scheduled for Monday, June 21, 2021 at 2:00 p.m., ET Event to Spotlight…
PRESS RELEASE RESULTS FROM MASITINIB STUDY AB12005 IN PANCREATIC CANCER PRESENTED AT THE ASCO ANNUAL…
Company’s fifth and sixth awards recognize excellence and innovation in security program management ANDOVER, Mass.,…
New product capability makes it easy for marketing teams to gather key data points and…
Program to Launch in the United States and to be expanded in Canada, Brazil and…
FinOps allows enterprises to optimize total cloud infrastructure costswithout sacrificing performance or efficiency NEW YORK,…